Percutaneous Device Closure in Atrial Septal Defect: Impact on Atrial and Ventricular Dimensions and Functions
Vaibhav Manohar Mahalle, Akash Lohakare, Vaibhav Raut, Anuj Chaturvedi, Gajendra Manakshe, Prithvi Sanjay Mundada, Karan SinghBackground:
Atrial septal defect (ASD) is one of the most common congenital heart diseases, with an incidence of 1.6 per thousand live births. In adults, it is 3rd most common congenital heart disease. Timely intervention in ASD prevents long-term complications such as pulmonary hypertension, atrial arrhythmias, and congestive heart failure, and it also improves the quality of life of the patients. Both the treatment options, namely surgical and percutaneous device closure, are safe and effective, with the percutaneous approach being at an advantage of avoiding the need of sternotomy and cardiopulmonary bypass and having a better edge in preservation of RV systolic and diastolic function.
Aims and Objectives:
To study changes in right atrial and ventricular dimensions with functions pre and post device closure & to compare the biventricular dimensions with functions pre- and post-op, at 1, 3 and 6 months.
Materials and Methods:
We performed a single center prospective cohort study in patients undergoing transcatheter device closure of ASD to study the improvement in structural and functional changes in heart with the help of two-dimensional Echocardiography.
Result:
We found noticeable improvement in left atrial reservoir and contraction function and also resolution of Right Atrium (RA) and Right Ventricle (RV) functional abnormalities, and favorable changes in pulmonary arterial pressure and paradoxical septal motion.
Conclusion:
These changes can be the forerunner of improvement in overall cardiac function and quality of life for the patient.